Information Library

Our Expertise

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title
  • Mapping the Future in Oncology Drug Development

    August 27, 2010
    Industry veterans Harish Dave and Eric Groves summarize key findings of Quintiles’ ASCO Ancillary Event, Mapping the Future in Oncology Drug Development

  • ISPOR 13th Annual European Congress

    November 6 - November 9, 2010
    Quintiles will be exhbiting, sponsoring and presenting at ISPOR's 13th Annual European Congress, November 6-9, 2010 in Prague.

  • A Blueprint for Clinical/Commercial Convergence

    August 5, 2010
    The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities.

  • A Focus on CNS

    July 28, 2010
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • CRO Perspective

    July 7, 2010
    Tom Grundstrom's presentation at DIA US 2010, CRO Perspective

  • Accelerated Access

    June 2, 2010
    Quintiles drew on extensive experience, a thorough understanding of the disease state and a myriad of tools in the Quintiles recruitment arsenal for a comprehensive solution to reach the right patients at the right time.

  • EMA’s Guidance on New Antidiabetic Drug Development

    May 12, 2010
    Assessing the EMA’s Guidance on New Antidiabetic Drug Development In January 2010, the European Medicines Agency (EMA) issued a draft guideline on antidiabetic drug development

  • Bridging Cultures

    May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • Focused Co-Promotion

    May 9, 2010
    Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth.

  • Mapping the Future in Oncology Drug Development

    June 5, 2010
    Improving the development of oncology drugs is a high priority in order to enhance patient outcomes.

Page 1 of 4 (32 results)

Subscribe to Email Based on Your Interests

Set preferences